BIOMAT Database Logo BIOMAT Database Logo

Neoantigen-Targeting Vaccine Promotes T-Cell Response in Glioblastoma. 2019

Jeffrey I Traylor, and Praveen Satarasinghe, and John S Kuo
Department of Neurosurgery Mulva Clinic for the Neurosciences Dell Medical School The University of Texas at Austin Austin, Texas.

UI MeSH Term Description Entries

Related Publications

Jeffrey I Traylor, and Praveen Satarasinghe, and John S Kuo
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial.
January 2019, Nature,
Jeffrey I Traylor, and Praveen Satarasinghe, and John S Kuo
Adenoviral-based vaccine promotes neoantigen-specific CD8+ T cell stemness and tumor rejection.
August 2022, Science translational medicine,
Jeffrey I Traylor, and Praveen Satarasinghe, and John S Kuo
Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma.
January 2019, Oncoimmunology,
Jeffrey I Traylor, and Praveen Satarasinghe, and John S Kuo
T-cell Receptor Gene Therapy Clinically Targeting a TP53 Public Neoantigen.
August 2022, Cancer immunology research,
Jeffrey I Traylor, and Praveen Satarasinghe, and John S Kuo
Therapeutic high affinity T cell receptor targeting a KRASG12D cancer neoantigen.
September 2022, Nature communications,
Jeffrey I Traylor, and Praveen Satarasinghe, and John S Kuo
The clonal hydra: neoantigen-specific T-cell response in germ cell tumors.
January 2024, Haematologica,
Jeffrey I Traylor, and Praveen Satarasinghe, and John S Kuo
mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer.
November 2020, The Journal of clinical investigation,
Jeffrey I Traylor, and Praveen Satarasinghe, and John S Kuo
Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses.
December 2021, Cell,
Jeffrey I Traylor, and Praveen Satarasinghe, and John S Kuo
Lymph node-targeting adjuvant/neoantigen-codelivering vaccines for combination glioblastoma radioimmunotherapy.
January 2023, Theranostics,
Jeffrey I Traylor, and Praveen Satarasinghe, and John S Kuo
Modeling the specific CD4+ T cell response against a tumor neoantigen.
April 2015, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!